Mupirocin Nasal Ointment Significantly Reduces Severe Acute Radiation Oral Mucositis in Nasopharyngeal Cancer Patients: Insights from a Phase 3 Trial
Posted inClinical Updates Wellness & Lifestyle

Mupirocin Nasal Ointment Significantly Reduces Severe Acute Radiation Oral Mucositis in Nasopharyngeal Cancer Patients: Insights from a Phase 3 Trial

A phase 3 trial demonstrates that mupirocin nasal ointment used for bacterial decolonization effectively lowers severe acute radiation oral mucositis rates, improves quality of life, and reduces Staphylococcus aureus colonization in nasopharyngeal cancer patients undergoing radiotherapy.